Reuse of a living donor kidney: A case study

Reuse of a previously transplanted solid organ for another recipient prevents waste of functioning organs. Here, we present a case of a kidney transplant in which the donor had previously received a kidney from a living donor 6 years earlier. We discuss system inefficiencies and gaps that complicate clinical decision making in this context. For example, during allocation donor ID, KDPI and HLA typing misrepresent the kidney that is from a prior donor potentially confounding virtual crossmatching. In addition, samples of PBMC received from the donor are insufficient for physical crossmatching. As well, peri-operative and post-transplant management in this context requires assessment of donor specific antibodies to the current and prior donor.

Authors

Institutions

Publication Details

Journal
Human Immunology
Published
2026-01-16
DOI
https://doi.org/10.1016/j.humimm.2026.111656
Primary Topic
Renal Transplantation Outcomes and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Reuse of a living donor kidney: A case study

Justin H. Nguyen, N. Nassiri, J. Tao, Y. Yin et al.
Human Immunology
Renal Transplantation Outcomes and Treatments
article

Reuse of a living donor kidney: A case study

Justin H. Nguyen, N. Nassiri, J. Tao, Y. Yin, PT. Pham, F. Prewitt, MJ. Hickey, E. Kendrick, EF. Reed, JL. Veale
article en

Abstract

Reuse of a previously transplanted solid organ for another recipient prevents waste of functioning organs. Here, we present a case of a kidney transplant in which the donor had previously received a kidney from a living donor 6 years earlier. We discuss system inefficiencies and gaps that complicate clinical decision making in this context. For example, during allocation donor ID, KDPI and HLA typing misrepresent the kidney that is from a prior donor potentially confounding virtual crossmatching. In addition, samples of PBMC received from the donor are insufficient for physical crossmatching. As well, peri-operative and post-transplant management in this context requires assessment of donor specific antibodies to the current and prior donor.

Human ImmunologyVol. 87(3)
UCLA Health (US), UCLA Medical Center (US), Olive View-UCLA Medical Center (US)
Peace, Justice and strong institutions
Openalex Percentile: Top 87%
Renal Transplantation Outcomes and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.